PRECLINICAL MECHANISTIC INVESTIGATION OF THE FIRST-IN-CLASS SIK2/SIK3 INHIBITOR GLPG3970 IN AN EXPERIMENTAL MODEL OF IBD

St├ęphanie Lavazais  1     Adrien Cosson     Didier Merciris     Carole Delachaume     Laetitia Perret     Anne Gigout     Nicolas Desroy     David AMANTINI     Steve De Vos  2    
1 Galapagos SASU, Romainville, France
2 Galapagos NV, Mechelen, Belgium

Topic
Disease Mechanisms, IBD, Immunology

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing